Chester County News and Community Website
WAYNE, PA — Ecovyst (NYSE: ECVT) raised its 2026 earnings outlook after first-quarter sales climbed 50%, driven by stronger sulfuric acid demand, refinery activity, and contributions from recently acquired production …
Ecovyst Raises Outlook After Sulfuric Acid Sales Surge Read More
AUDUBON, PA — Globus Medical (NYSE: GMED) raised its 2026 earnings outlook after first-quarter revenue climbed 27% and profit growth outpaced sales gains, driven by spine procedure demand and contributions …
Globus Medical Raises 2026 Profit Outlook After Q1 Surge Read More
WILMINGTON, DE — Onfolio Holdings (Nasdaq: ONFO, ONFOW) said it will report first-quarter financial results before markets open on Monday and host a conference call to discuss performance as investors …
Onfolio Sets First-Quarter Earnings Call for May 18 Read More
WILMINGTON, DE — Acorn Energy (Nasdaq: ACFN) reported a 28% decline in first-quarter revenue as hardware sales tied to a large cellphone provider deployment fell sharply, though recurring monitoring revenue …
Acorn Energy Revenue Falls as Hardware Sales Slow Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) said it remains on track to submit a New Drug Application in the second half of 2026 for QTORIN rapamycin after reporting …
Palvella Eyes 2027 Launch After Positive Phase 3 Results Read More
KING OF PRUSSIA, PA — Vertex, Inc. (Nasdaq: VERX) raised its full-year adjusted EBITDA outlook after launching a restructuring initiative aimed at improving profitability while expanding investment in artificial intelligence …
Vertex Raises Profit Outlook After Cost-Cutting Plan Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (Nasdaq: ACRS) outlined plans for multiple mid- and late-stage clinical milestones this year as the biotechnology company advances experimental treatments for asthma, atopic dermatitis …
Aclaris Expands Immunology Pipeline Ahead of Key Trial Data Read More
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) expects interim clinical data from two experimental cancer therapies later this year as the biotechnology company advances multiple bispecific antibody programs targeting …
Context Therapeutics Advances Cancer Drug Pipeline Toward Data Readouts Read More
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) received U.S. Food and Drug Administration acceptance for its application seeking approval of lorundrostat for uncontrolled or resistant hypertension, moving the company …
Mineralys Advances Hypertension Drug Toward FDA Decision Read More
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) reported first-quarter Rezdiffra sales of $311.3 million, more than doubling from a year earlier as physician adoption accelerated for the company’s liver …
Madrigal Rezdiffra Sales More Than Double in First Quarter Read More